160 related articles for article (PubMed ID: 28328831)
1. Expression characteristics of proteins of IGF-1R, p-Akt, and survivin in papillary thyroid carcinoma patients with type 2 diabetes mellitus.
Yan Y; Hu F; Wu W; Ma R; Huang H
Medicine (Baltimore); 2017 Mar; 96(12):e6393. PubMed ID: 28328831
[TBL] [Abstract][Full Text] [Related]
2. Expression and significance of IGF-1 and IGF-1R in thyroid nodules.
Liu YJ; Qiang W; Shi J; Lv SQ; Ji MJ; Shi BY
Endocrine; 2013 Aug; 44(1):158-64. PubMed ID: 23288662
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of survivin expression and its prognostic value in papillary thyroid carcinoma.
Selemetjev S; Dencic TI; Marecko I; Jankovic J; Paunovic I; Savin S; Cvejic D
Pathol Res Pract; 2014 Jan; 210(1):30-4. PubMed ID: 24199968
[TBL] [Abstract][Full Text] [Related]
4. Role of survivin in the pathogenesis of papillary thyroid carcinoma.
Li JY; Shi J; Sang JF; Yao YZ; Wang XC; Su L
Genet Mol Res; 2015 Nov; 14(4):15102-11. PubMed ID: 26634473
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
Meng XY; Zhang Q; Li Q; Lin S; Li J
J Int Med Res; 2014 Jun; 42(3):619-27. PubMed ID: 24670538
[TBL] [Abstract][Full Text] [Related]
6. HSP90 inhibitor NVP-AUY922 induces cell apoptosis by disruption of the survivin in papillary thyroid carcinoma cells.
Liu J; Sun W; Dong W; Wang Z; Qin Y; Zhang T; Zhang H
Biochem Biophys Res Commun; 2017 May; 487(2):313-319. PubMed ID: 28412368
[TBL] [Abstract][Full Text] [Related]
7. Concomitant high expression of survivin and vascular endothelial growth factor-C is strongly associated with metastatic status of lymph nodes in papillary thyroid carcinoma.
Selemetjev S; Savin S; Paunovic I; Tatic S; Cvejic D
J Cancer Res Ther; 2018; 14(Supplement):S114-S119. PubMed ID: 29578160
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus.
Kang YY; Li JJ; Sun JX; Wei JX; Ding C; Shi CL; Wu G; Li K; Ma YF; Sun Y; Qiao H
Clin Transl Oncol; 2021 Dec; 23(12):2536-2547. PubMed ID: 34245428
[TBL] [Abstract][Full Text] [Related]
9. Suppressed Krüppel‑like factor 17 expression induces tumor proliferation, metastasis and a poor prognosis in papillary thyroid carcinoma.
Ye WC; Gao L; Huang J; Fang XM; Xie G
Mol Med Rep; 2014 Oct; 10(4):2087-92. PubMed ID: 25109837
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of oncoprotein expressions in thyroid papillary carcinoma.
Balta AZ; Filiz AI; Kurt Y; Sucullu I; Yucel E; Akin ML
Med Oncol; 2012 Jun; 29(2):734-41. PubMed ID: 21547408
[TBL] [Abstract][Full Text] [Related]
11. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
12. The expression difference of insulin-like growth factor 1 receptor in breast cancers with or without diabetes.
Xin C; Jing D; Jie T; Wu-Xia L; Meng Q; Ji-Yan L
J Cancer Res Ther; 2015; 11(2):295-9. PubMed ID: 26148588
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum concentrations of IGF-1 and IGF-1R in patients with thyroid cancers.
Lawnicka H; Motylewska E; Borkowska M; Kuzdak K; Siejka A; Swietoslawski J; Stepien H; Stepien T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):77-83. PubMed ID: 31132076
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer.
Dong W; Li J; Zhang H; Huang Y; He L; Wang Z; Shan Z; Teng W
Int J Clin Exp Pathol; 2015; 8(6):7149-56. PubMed ID: 26261608
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
[TBL] [Abstract][Full Text] [Related]
16. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
[TBL] [Abstract][Full Text] [Related]
17. Expression characteristics of proteins of the insulin-like growth factor axis in non-small cell lung cancer patients with preexisting type 2 diabetes mellitus.
Ding J; Tang J; Chen X; Men HT; Luo WX; Du Y; Ge J; Li C; Chen Y; Cheng K; Qiu M; Liu JY
Asian Pac J Cancer Prev; 2013; 14(10):5675-80. PubMed ID: 24289561
[TBL] [Abstract][Full Text] [Related]
18. Effects of insulin analogs and glucagon-like peptide-1 receptor agonists on proliferation and cellular energy metabolism in papillary thyroid cancer.
He L; Zhang S; Zhang X; Liu R; Guan H; Zhang H
Onco Targets Ther; 2017; 10():5621-5631. PubMed ID: 29200876
[TBL] [Abstract][Full Text] [Related]
19. Thyrocyte-specific deletion of insulin and IGF-1 receptors induces papillary thyroid carcinoma-like lesions through EGFR pathway activation.
Ock S; Ahn J; Lee SH; Kim HM; Kang H; Kim YK; Kook H; Park WJ; Kim S; Kimura S; Jung CK; Shong M; Holzenberger M; Abel ED; Lee TJ; Cho BY; Kim HS; Kim J
Int J Cancer; 2018 Nov; 143(10):2458-2469. PubMed ID: 30070361
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycin-mediated increases in survivin expression.
Oh SH; Jin Q; Kim ES; Khuri FR; Lee HY
Clin Cancer Res; 2008 Mar; 14(5):1581-9. PubMed ID: 18316583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
